OFI Invest Asset Management Increases Stock Position in HCA Healthcare, Inc. $HCA

OFI Invest Asset Management lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.4% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 63,826 shares of the company’s stock after buying an additional 5,483 shares during the period. OFI Invest Asset Management’s holdings in HCA Healthcare were worth $24,452,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Nuveen LLC acquired a new stake in shares of HCA Healthcare in the 1st quarter valued at about $569,217,000. Pacer Advisors Inc. lifted its stake in HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after purchasing an additional 1,329,618 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of HCA Healthcare by 49.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after acquiring an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP acquired a new position in HCA Healthcare in the 1st quarter valued at approximately $164,835,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.30% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $414.73 on Friday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $439.01. The stock has a market capitalization of $97.04 billion, a P/E ratio of 17.43, a price-to-earnings-growth ratio of 1.31 and a beta of 1.40. The business’s 50 day simple moving average is $405.12 and its two-hundred day simple moving average is $375.85.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the prior year, the company posted $5.50 earnings per share. The company’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on HCA shares. Morgan Stanley reduced their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a report on Monday, July 28th. Robert W. Baird upped their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a report on Thursday, August 14th. KeyCorp upped their price objective on shares of HCA Healthcare from $370.00 to $465.00 and gave the stock an “overweight” rating in a research report on Wednesday. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of HCA Healthcare in a research note on Wednesday. Finally, Barclays raised their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $422.31.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.